SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-011970
Filing Date
2020-10-29
Accepted
2020-10-29 07:12:03
Documents
14
Period of Report
2020-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plx-20201029x8k.htm   iXBRL 8-K 34893
2 EX-99.1 plx-20201029xex99d1.htm EX-99.1 239058
3 GRAPHIC plx-20201029xex99d1001.jpg GRAPHIC 5964
  Complete submission text file 0001558370-20-011970.txt   420264

Data Files

Seq Description Document Type Size
4 EX-101.SCH plx-20201029.xsd EX-101.SCH 3250
5 EX-101.LAB plx-20201029_lab.xml EX-101.LAB 16114
6 EX-101.PRE plx-20201029_pre.xml EX-101.PRE 10898
7 EXTRACTED XBRL INSTANCE DOCUMENT plx-20201029x8k_htm.xml XML 4912
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 201270482
SIC: 2836 Biological Products, (No Diagnostic Substances)